2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Specimen Handling
456
Magnetic Resonance Spectroscopy
347
pembrolizumab
287
Biopsy
245
Carboplatin
228
Cisplatin
194
Cyclophosphamide
178
Paclitaxel
160
Nivolumab
153
Gemcitabine
147
Bevacizumab
126
Radiotherapy
124
Dexamethasone
110
Pemetrexed
101
fludarabine
96
Fluorouracil
95
atezolizumab
93
Radiation
92
Docetaxel
90
venetoclax
89
Doxorubicin
88
durvalumab
85
Oxaliplatin
85
Rituximab
84
Leucovorin
81
Capecitabine
76
Prednisone
73
Lenalidomide
70
X-Rays
69
Etoposide
67
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hizentra
×
30 days
×
Clear all
NCT07582432
2026-05-12
SIGMA
Grifols Biologicals, LLC
Phase 3
Recruiting
49 enrolled